The selection and schedule of treatment should depend on patient preference and toxicity potential, according to Azka Ali, MD.

Equities research analysts at StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a note ...

Ashley Joyes and P.A. Belore co-founded Cold Crowns to offer rental cold caps for chemotherapy patients to retain hair, ...

Mersana Therapeutics (MRSN) announced positive initial clinical data from the Phase 1 dose escalation and backfill cohorts for emiltatug ...

In view of this centennial, and the current stagnation in antibacterial pipelines, it seems timely to reflect on the ground-breaking contributions of Ehrlich to the birth of chemotherapy (see Ref.